Voice Therapy Per the Rehabilitation Treatment Specification System

Conditions

• Muscle Tension Dysphonia

Eligibility Criteria

Sex

ALL

Age

14 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Standard of care voice therapy with novice clinician RTSS-Voice documentation — BEHAVIORAL
  Voice therapy is individually tailored to each patient and typically includes behavioral ingredients (e.g., applying pressure to the anterior neck, practice voicing in various ways, feedback on performance, provide information on the importance of therapy concepts) to modify the patient's auditory, somatosensory, vocal, musculoskeletal, respiratory, and mental functions. During this time, the treating clinicians will be trained to use the RTSS-Voice in their clinical documentation.
• Standard of care voice therapy with expert clinician RTSS-Voice documentation — BEHAVIORAL
  Voice therapy is individually tailored to each patient and typically includes behavioral ingredients (e.g., applying pressure to the anterior neck, practice voicing in various ways, feedback on performance, provide information on the importance of therapy concepts) to modify the patient's auditory, somatosensory, vocal, musculoskeletal, respiratory, and mental functions. During this time, the treating clinicians will have completed their RTSS-Voice training and using the RTSS-Voice in their clinical documentation.

Study Details

The goal of this study is to evaluate if using evidence-based, standard ingredient and target codes from the Rehabilitation Treatment Specification System - Voice Therapy (RTSS-Voice) in standard of care voice therapy documentation can improve outcomes for patients with muscle tension dysphonia (MTD). The main question it aims to answer is: Since the RTSS-Voice will help clinicians think about their treatment more specifically and in relation to nine evidence-based therapies, will its adoption be associated with improved outcomes? Clinicians across five voice centers will be asked to use the RTSS-Voice to document their voice therapy sessions for patients with MTD. Researchers will compare changes in outcomes between two groups of patients: those treated during the clinician's first year using the RTSS-Voice versus those treated during the clinician's second year using the RTSS-Voice.

Key Dates

Start date

Feb 3, 2026

Status verified

May 2026

Primary completion

Jun 29, 2027

Completion

Jun 29, 2027

Study Design

Enrollment

600 participants (estimated)

Allocation

NON_RANDOMIZED

Intervention model

SEQUENTIAL

Primary purpose

HEALTH_SERVICES_RESEARCH

Arms

• Experimental: First Year of RTSS-Voice use
  These 300 patients from five Voice Centers will receive standard of care voice therapy where their treating clinicians will be trained to use the RTSS-Voice in their documentation.
• Experimental: Second Year of RTSS-Voice use
  These 300 patients from five Voice Centers will receive standard of care voice therapy where their treating clinicians have already been trained to use the RTSS-Voice in their documentation.

Primary Outcome Measure

Voice Health Index (VHI) [ Time Frame: pre-intervention and immediately after the intervention ]

Central Contacts

• Jarrad Van Stan, PhD, CCC-SLP
  617-643-8410
  [email protected]

Locations (5)

Find similar trials in Atlanta, GA

Related Studies

• Imaging Genetics of Laryngeal Dystonia
  Recruiting · Kristina Simonyan · Boston, Massachusetts
• Project 4: Ambulatory Biofeedback and Voice Therapy for Patients With Vocal Hyperfunction
  EARLY_PHASE1 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
• Translaryngeal Vibration for Hyperfunctional Voice Disorders
  PHASE3 · Recruiting · Texas Christian University · Fort Worth, Texas